Skip to main content
. 2025 Feb 4;19(2):jjaf022. doi: 10.1093/ecco-jcc/jjaf022

Table 2.

Inflammatory bowel disease characteristics.

Control (N =  = 200) Case (N =  = 87) P-value
Subtype .481
 CD 89 (44.5%) 32 (36.8%)
 UC 105 (52.5%) 52 (59.8%)
 IC 6 (3.0%) 3 (3.4%)
Maximal endoscopic extent of CD in past .861
 Ileal 20 (22.5%) 7 (21.9%)
 Ileocolonic 56 (62.9%) 19 (59.4%)
 Colonic 13 (14.6%) 6 (18.8%)
Maximal endoscopic extent of UC in past .0321
 Proctitis 10 (9.5%) 1 (1.9%)
 Left-sided 19 (18.1%) 4 (7.7%)
 Extensive 74 (70.5%) 46 (88.5%)
Maximal endoscopic extent of IC in past
 Ileocolonic 3 (1.5%) 2 (2.3%) .631
 Colonic 3 (1.5%) 1 (1.1%) .821
Perianal disease presentb 25 (28.1%) 16 (50.0%) .0251
Backwash ileitis present 8 (7.6%) 15 (28.8%) <.001a
PSC present 15 (7.5%) 25 (28.7%) <.001a
History of cholangiocarcinoma 3 (1.5%) 6 (6.9%) .021
Prior liver transplant 5 (2.5%) 11 (12.6%) <.001a
Family history of colorectal cancer 24 (12.0%) 12 (13.8%) .891
Current/former tobacco use 57 (28.5%) 24 (27.6%) .871
Previous surgery (prior to 1/1/2007) .251
 Ileocecal resection 14 (56.0%) 2 (25.0%)
 Colon segment resection 2 (8.0%) 2 (25.0%)
 Hemicolectomy 2 (8.0%) 2 (25.0%)
 Other 7 (28.0%) 2 (25.0%)

Abbreviations: CD, Crohn’s disease; IC, indeterminate colitis; PSC, primary sclerosing cholangitis; UC, ulcerative colitis.

aPearson’s Chi-squared test.

bPatients with UC and IC were not included.